You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 8, August 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids

J. H. Talamo, S. Gollamudi, W. R. Green, Z. De La Cruz, V. Filatov and W. J. Stark
Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, MD 21205.

A 193-nm excimer laser system was used to create deep stromal ablations in seven New Zealand white rabbits and shallow ablations in three. Eyes were randomized for treatment with topical mitomycin C, steroids, and erythromycin; topical steroids and erythromycin; or topical erythromycin only. All treatment regimens were instituted twice daily for 14 days. All eyes reepithelialized normally within 3 to 5 days. During 10 weeks of follow-up, all eyes developed moderate reticular subepithelial haze without significant differences among treatment groups. Results of light, fluorescence, and electron microscopic examination showed anterior stromal scarring and markedly reduced new subepithelial collagen formation in the group treated with mitomycin C, corticosteroids, and erythromycin. Focal abnormalities of Descemet's membrane and endothelial abnormalities were present in all treatment groups. Combination therapy with topical steroids, mitomycin C, and erythromycin to control the corneal wound healing response after refractive laser surgery appears promising and warrants further study.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mitomycin C Upregulates IL-8 and MCP-1 Chemokine Expression via Mitogen-Activated Protein Kinases in Corneal Fibroblasts
Chou et al.
IOVS 2007;48:2009-2016.
ABSTRACT | FULL TEXT  

Mitomycin C-Induced Reduction of Keratocytes and Fibroblasts after Photorefractive Keratectomy
Kim et al.
IOVS 2004;45:2978-2984.
ABSTRACT | FULL TEXT  

Urokinase-Type Plasminogen Activator to Prevent Haze after Photorefractive Keratectomy, and Pregnancy as a Risk Factor for Haze in Rabbits
Csutak et al.
IOVS 2004;45:1329-1333.
ABSTRACT | FULL TEXT  

Evaluation for Safety of Cultured Corneal Fibroblasts with Cotreatment of Alcohol and Mitomycin C
Kim et al.
IOVS 2004;45:86-92.
ABSTRACT | FULL TEXT  

Apoptosis in Keratocytes Caused by Mitomycin C
Kim et al.
IOVS 2003;44:1912-1917.
ABSTRACT | FULL TEXT  

Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias
Kemp et al.
Br. J. Ophthalmol. 2002;86:31-34.
ABSTRACT | FULL TEXT  

Inflammatory Response in the Early Stages of Wound Healing After Excimer Laser Keratectomy
O'Brien et al.
Arch Ophthalmol 1998;116:1470-1474.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.